Immunovant
Price & Volume
Stats
See more52W Range | $24.61-$45.58 |
Market Cap | $3.8B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.21 |
News
See moreYahoo Finance • 2 months ago
Is Immunovant, Inc. (IMVT) the Worst Performing Stock to Buy on the Dip?
Yahoo Finance • 10 months ago
Should You Invest in Immunovant (IMVT)?
Yahoo Finance • 11 months ago
11 Stocks Insiders and Billionaires Are Crazy About
Yahoo Finance • 12 months ago
Immunovant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential
About
CEO | Dr. Peter Salzmann M.B.A., M.D. |
Address | 320 West 37th Street, New York, NY, United States, 10018 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 207 |
